TROY Modulates Cancer Stem-Like Cell Properties and Gefitinib Resistance Through EMT Signaling in Non–Small Cell Lung Cancer
Linying Wu(Zhejiang University), Yuehong Wang(Zhejiang University)
Cited by 8
Related Papers
Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with <i>T790M</i> mutations
|Oncotarget|2016|24
Low-dose blood BTEX are associated with pulmonary function through changes in inflammatory markers among US adults: NHANES 2007–2012
|Environmental Science and Pollution Research|2023|9